These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease. Collier TJ, Sortwell CE, Elsworth JD, Taylor JR, Roth RH, Sladek JR, Redmond DE. J Comp Neurol; 2002 Jan 21; 442(4):320-30. PubMed ID: 11793337 [Abstract] [Full Text] [Related]
4. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice. Cui YF, Hargus G, Xu JC, Schmid JS, Shen YQ, Glatzel M, Schachner M, Bernreuther C. Brain; 2010 Jan 21; 133(Pt 1):189-204. PubMed ID: 19995872 [Abstract] [Full Text] [Related]
5. Neuroprotection in Parkinson models varies with toxin administration protocol. Anderson DW, Bradbury KA, Schneider JS. Eur J Neurosci; 2006 Dec 21; 24(11):3174-82. PubMed ID: 17156378 [Abstract] [Full Text] [Related]
6. Cross-talk between stem cells and the dysfunctional brain is facilitated by manipulating the niche: evidence from an adhesion molecule. Ourednik V, Ourednik J, Xu Y, Zhang Y, Lynch WP, Snyder EY, Schachner M. Stem Cells; 2009 Nov 21; 27(11):2846-56. PubMed ID: 19785036 [Abstract] [Full Text] [Related]
7. Potential neuroprotective effect of low dose whole-body gamma-irradiation against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in C57 mice. Liang Y, Li S, Zou Q, Su B. Neurosci Lett; 2006 Jun 12; 400(3):213-7. PubMed ID: 16540245 [Abstract] [Full Text] [Related]
8. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease. Liu LX, Chen WF, Xie JX, Wong MS. Neurosci Res; 2008 Feb 12; 60(2):156-61. PubMed ID: 18054104 [Abstract] [Full Text] [Related]
9. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice. Muramatsu Y, Kurosaki R, Watanabe H, Michimata M, Matsubara M, Imai Y, Araki T. Glia; 2003 May 12; 42(3):307-13. PubMed ID: 12673835 [Abstract] [Full Text] [Related]
10. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway. Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM. J Neurosci Res; 2004 May 15; 76(4):539-50. PubMed ID: 15114626 [Abstract] [Full Text] [Related]
11. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse. Liu J, Wang YY, Liu L, Wang QD, Yuan ZY, Zhang ZX, Gu P, Wang MW. Neurosci Lett; 2008 Dec 26; 448(2):184-8. PubMed ID: 18977411 [Abstract] [Full Text] [Related]
12. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study. Shin JY, Park HJ, Ahn YH, Lee PH. J Neurochem; 2009 Nov 26; 111(4):1042-50. PubMed ID: 19765187 [Abstract] [Full Text] [Related]
13. Increased host neuronal survival and motor function in BMT Parkinsonian mice: involvement of immunosuppression. Keshet GI, Tolwani RJ, Trejo A, Kraft P, Doyonnas R, Clayberger C, Weimann JM, Blau HM. J Comp Neurol; 2007 Oct 20; 504(6):690-701. PubMed ID: 17722033 [Abstract] [Full Text] [Related]
14. Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice. Ohashi S, Mori A, Kurihara N, Mitsumoto Y, Nakai M. Neurosci Lett; 2006 Jun 19; 401(1-2):183-7. PubMed ID: 16581184 [Abstract] [Full Text] [Related]
15. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Sawada H, Hishida R, Hirata Y, Ono K, Suzuki H, Muramatsu S, Nakano I, Nagatsu T, Sawada M. J Neurosci Res; 2007 Jun 19; 85(8):1752-61. PubMed ID: 17469135 [Abstract] [Full Text] [Related]
16. Survival and differentiation of transplanted neural stem cells in mice brain with MPTP-induced Parkinson disease. Li XK, Guo AC, Zuo PP. Acta Pharmacol Sin; 2003 Dec 19; 24(12):1192-8. PubMed ID: 14653943 [Abstract] [Full Text] [Related]
17. Fluoro-Jade C can specifically stain the degenerative neurons in the substantia nigra of the 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine-treated C57BL/6 mice. Bian GL, Wei LC, Shi M, Wang YQ, Cao R, Chen LW. Brain Res; 2007 May 30; 1150():55-61. PubMed ID: 17397812 [Abstract] [Full Text] [Related]
18. Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism. Faherty CJ, Raviie Shepherd K, Herasimtschuk A, Smeyne RJ. Brain Res Mol Brain Res; 2005 Mar 24; 134(1):170-9. PubMed ID: 15790541 [Abstract] [Full Text] [Related]
19. New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis. Tandé D, Höglinger G, Debeir T, Freundlieb N, Hirsch EC, François C. Brain; 2006 May 24; 129(Pt 5):1194-200. PubMed ID: 16481374 [Abstract] [Full Text] [Related]
20. Alteration in the differentiation-related molecular expression in the subventricular zone in a mouse model of Parkinson's disease. Oizumi H, Hayashita-Kinoh H, Hayakawa H, Arai H, Furuya T, Ren YR, Yasuda T, Seki T, Mizuno Y, Mochizuki H. Neurosci Res; 2008 Jan 24; 60(1):15-21. PubMed ID: 17963913 [Abstract] [Full Text] [Related] Page: [Next] [New Search]